Abstract
Chemotherapy-induced respiratory failure is being increasingly recognized as a cause of respiratory failure in the intensive care unit. The frequency of chemotherapy-induced respiratory failure is low, however with increasing number of patients receiving new chemotherapeutic agents more cases can be expected to be seen. Chemotherapy-induced respiratory failure can be due to bronchospasm and hypersensitivity reactions, pulmonary hemorrhage, interstitial pneumonitis, eosinophilic pneumonia, and non-cardiogenic pulmonary edema. Pulmonary and critical care physicians should be aware of the clinical presentation of chemotherapy-induced respiratory failure.
Keywords: Pulmonary toxicity, pneumonitis, respiratory failure, chemotherapy
Current Respiratory Medicine Reviews
Title: Respiratory Failure in Cancer Patients: Non-Infectious Complications of Antineoplastic Agents for Solid Tumors
Volume: 3 Issue: 3
Author(s): Bobbak Vahid and Paul E. Marik
Affiliation:
Keywords: Pulmonary toxicity, pneumonitis, respiratory failure, chemotherapy
Abstract: Chemotherapy-induced respiratory failure is being increasingly recognized as a cause of respiratory failure in the intensive care unit. The frequency of chemotherapy-induced respiratory failure is low, however with increasing number of patients receiving new chemotherapeutic agents more cases can be expected to be seen. Chemotherapy-induced respiratory failure can be due to bronchospasm and hypersensitivity reactions, pulmonary hemorrhage, interstitial pneumonitis, eosinophilic pneumonia, and non-cardiogenic pulmonary edema. Pulmonary and critical care physicians should be aware of the clinical presentation of chemotherapy-induced respiratory failure.
Export Options
About this article
Cite this article as:
Bobbak Vahid and Paul E. Marik , Respiratory Failure in Cancer Patients: Non-Infectious Complications of Antineoplastic Agents for Solid Tumors, Current Respiratory Medicine Reviews 2007; 3 (3) . https://dx.doi.org/10.2174/157339807781387544
DOI https://dx.doi.org/10.2174/157339807781387544 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Roles of Neurotensin and its Analogues in Pain
Current Pharmaceutical Design An Efficient Organocatalyst for Environmentally benign Synthesis of Pyranopyrazole Derivatives in Aqueous Medium
Letters in Organic Chemistry Ambulatory Blood Pressure and Diabetes: Targeting Nondipping
Current Diabetes Reviews In-hospital Falls in Older Patients: The Risk Factors and The Role of Hyponatraemia
Current Aging Science Optimizing the Management of Uncontrolled/Resistant Hypertension. The Importance of Sleep Apnoea Syndrome
Current Vascular Pharmacology Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Novel Strategies in the Treatment of Pulmonary Arterial Hypertension
Current Drug Targets Recent Developments in Drug Design of NO-donor Hybrid Compounds
Mini-Reviews in Medicinal Chemistry Bortezomib – First Therapeutic Proteasome Inhibitor for Cancer Therapy: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Neurologic Sequelae in Critical Illness: Evaluation and Outcomes
Current Respiratory Medicine Reviews Effective Use of Drugs to Counter Chemical Terrorism
Current Drug Therapy The No-Reflow Phenomenon in the Coronary Circulation
Cardiovascular & Hematological Agents in Medicinal Chemistry Expression of Mastoparan B, a Venom Peptide, Via Escherichia coli C43 (DE3) Coupled with an Artificial Oil Body-Cyanogen Bromide Technology Platform
Protein & Peptide Letters Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator
Current Pharmaceutical Design Management of Severe Abdominal Infections
Recent Patents on Anti-Infective Drug Discovery Vaccine Development for Group A Streptococcus Infections and Associated Diseases
Current Drug Targets Effects of Static Magnetic Fields on Blood Pressure in Animals and Humans
Current Hypertension Reviews Do RAS Inhibitors Protect the Brain from Cerebral Ischemic Injury?
Current Hypertension Reviews Some Peculiar Effects of NO-Synthase Inhibition on the Structure and Function of Cardiovascular System
Current Pharmaceutical Biotechnology Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry